97 related articles for article (PubMed ID: 6542157)
1. [Studies on human natural killer (NK) cell activity against cell lines derived from malignant urinary tract tumors. Part 3: Effects of OK432 on human NK cell activity and proliferation of tumor cells].
Hayakawa M; Marumo K; Nagakura K; Hata M; Fujioka T; Nakamura H; Murai M
Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1124-33. PubMed ID: 6542157
[No Abstract] [Full Text] [Related]
2. Effect of a streptococcal preparation (OK432) on natural killer activity of tumour-associated lymphoid cells in human ovarian carcinoma and on lysis of fresh ovarian tumour cells.
Colotta F; Rambaldi A; Colombo N; Tabacchi L; Introna M; Mantovani A
Br J Cancer; 1983 Oct; 48(4):515-25. PubMed ID: 6626452
[TBL] [Abstract][Full Text] [Related]
3. Cell regulatory and immunorestorative activity of picibanil (OK432).
Chirigos MA; Saito T; Talmadge JE; Budzynski W; Gruys E
Cancer Detect Prev Suppl; 1987; 1():317-28. PubMed ID: 3480058
[TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.
Yanagawa E; Uchida A; Micksche M
Cancer Immunol Immunother; 1984; 17(1):1-6. PubMed ID: 6563940
[TBL] [Abstract][Full Text] [Related]
5. Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes by the streptococcal preparation OK432.
Uchida A
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):81-4. PubMed ID: 2423823
[TBL] [Abstract][Full Text] [Related]
6. [Induction of activated natural killer cells by the streptococcal preparation OK432 (I). Induction from spleen cells of normal or tumor-bearing mouse primed in vivo and subsequently challenged in vitro with OK432].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Jul; 24(7):1370-8. PubMed ID: 2809371
[TBL] [Abstract][Full Text] [Related]
7. OK432-activated natural killer cells enhanced trastuzumab (Herceptin)-mediated antibody-dependent cellular cytotoxicity in patients with advanced cancer.
Sudo T; Aruga A; Shimizu K; Matsushita N; Takasaki K
Anticancer Res; 2006; 26(6B):4327-33. PubMed ID: 17201151
[TBL] [Abstract][Full Text] [Related]
8. [Successful adoptive immunotherapy with OK432-inducible activated natural killer cells on tumor-bearing mice].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2546-55. PubMed ID: 2614190
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of NK activation by OK-432 (Streptococcus pyogenes). I. Spontaneous release of NKCF and augmentation of NKCF production following stimulation with NK target cells.
Bonavida B; Katz J; Hoshino T
Cell Immunol; 1986 Oct; 102(1):126-35. PubMed ID: 3492275
[TBL] [Abstract][Full Text] [Related]
10. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432.
Christmas SE; Meager A; Moore M
Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735
[TBL] [Abstract][Full Text] [Related]
11. [In vivo augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432: characterization of effector cells and induction of interferon in sera (author's transl)].
Wakasugi H; Miyata M; Morioka Y; Oshimi K; Kasahara T; Takahashi K; Saito M; Ebina T
Nihon Gan Chiryo Gakkai Shi; 1981 Jun; 16(3):433-46. PubMed ID: 7320603
[No Abstract] [Full Text] [Related]
12. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
[TBL] [Abstract][Full Text] [Related]
13. Harnessing Natural Killer Cell Function for Genitourinary Cancers.
Bhardwaj N; Farkas AM; Gul Z; Sfakianos JP
Urol Clin North Am; 2020 Nov; 47(4):433-442. PubMed ID: 33008494
[TBL] [Abstract][Full Text] [Related]
14. [Role of interleukin 2 and interferon gamma in induction of activated natural killer cells by the streptococcal preparation OK432].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2504-12. PubMed ID: 2515233
[TBL] [Abstract][Full Text] [Related]
15. Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432.
Uchida A; Micksche M
J Natl Cancer Inst; 1983 Oct; 71(4):673-80. PubMed ID: 6413742
[TBL] [Abstract][Full Text] [Related]
16. [NK activities in cancer patients--their modification by an immunopotentiator].
Sasanami T; Fujishima A; Moriya Y; Imai K; Yachi A
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2186-92. PubMed ID: 7184392
[TBL] [Abstract][Full Text] [Related]
17. [Studies on human natural killer (NK) cell activity against cell lines derived from malignant urinary tract tumors. Part II: Specificity of NK cell activity of IFN-stimulated PBL against cell lines derived from malignant urinary tract tumors].
Hayakawa M; Schmitz-Dräger BJ; Ackerman R
Nihon Hinyokika Gakkai Zasshi; 1984 Jan; 75(1):43-52. PubMed ID: 6376902
[No Abstract] [Full Text] [Related]
18. Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.
Wakasugi H; Oshimi K; Miyata M; Morioka Y
J Clin Immunol; 1981 Jul; 1(3):154-62. PubMed ID: 6174541
[TBL] [Abstract][Full Text] [Related]
19. Effect of biological response modifier-streptococcal preparation OK-432 on NK/K cell system of gnotobiotic miniature swine.
Kim YB
Prog Clin Biol Res; 1985; 181():337-41. PubMed ID: 4063011
[No Abstract] [Full Text] [Related]
20. Effects of interleukin-2, OK-432 and interferon-gamma on in vitro induction of nonspecific killer cells by concanavalin A in mice.
Mizushima Y; Iwata M; Sato M; Yano S
Tohoku J Exp Med; 1986 Jan; 148(1):79-85. PubMed ID: 3085284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]